GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
2019-10-15 $18.93 $18.93 $18.87 $18.88 3 290 731
2019-10-14 $18.87 $18.92 $18.86 $18.92 1 899 106
2019-10-11 $18.92 $18.92 $18.85 $18.87 3 396 856
2019-10-10 $18.90 $18.92 $18.86 $18.88 3 027 317
2019-10-09 $18.86 $18.94 $18.85 $18.93 3 977 656
2019-10-08 $18.88 $18.90 $18.85 $18.86 7 924 722
2019-10-07 $18.87 $18.99 $18.87 $18.91 2 632 185
2019-10-04 $18.85 $18.93 $18.83 $18.90 4 537 816
2019-10-03 $18.89 $18.89 $18.83 $18.87 4 816 122
2019-10-02 $18.79 $18.87 $18.79 $18.86 2 865 005
2019-10-01 $18.88 $18.90 $18.81 $18.84 3 161 378
2019-09-30 $18.73 $18.95 $18.73 $18.86 4 750 936
2019-09-27 $18.81 $18.84 $18.75 $18.78 3 031 351
2019-09-26 $18.75 $18.83 $18.74 $18.81 3 201 965
2019-09-25 $18.78 $18.83 $18.72 $18.76 2 071 725
2019-09-24 $18.66 $18.82 $18.65 $18.78 3 057 050
2019-09-23 $18.64 $18.70 $18.60 $18.63 5 451 001
2019-09-20 $18.65 $18.72 $18.60 $18.64 7 129 125
2019-09-19 $18.75 $18.78 $18.65 $18.66 6 325 310
2019-09-18 $18.67 $18.90 $18.66 $18.71 9 484 343
2019-09-17 $18.50 $18.82 $18.50 $18.70 14 652 245
2019-09-16 $18.48 $18.88 $18.34 $18.50 49 580 986
2019-09-13 $9.75 $10.14 $9.72 $10.06 685 715
2019-09-12 $9.81 $9.84 $9.57 $9.74 464 464
2019-09-11 $9.23 $9.77 $9.12 $9.75 794 531
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT